Central Nervous System (CNS) Therapeutics Market by Disease Type (Infectious Diseases, Neurodegenerative Diseases, Autoimmune & Inflammatory Diseases, Genetic Disorders, Cancers, Trauma, and Psychiatric Disorders) and Application (Hospital, Clinic, Homecare, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
|
A05143
|
Pages: NA
|
May 2020 |
625 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
The central nervous system (CNS) is a vital part of the nervous system that consists the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. However, CNS disorders such as neurodegenerative diseases, autoimmune & inflammatory diseases, genetic disorders, cancers, and others affect the structure and function of the brain or spinal cord. Thus, CNS therapeutics are used to treat these disorders.
The growth of the CNS therapeutics market is primarily driven by advancements in diagnostics, therapeutics, and drug discovery techniques. Moreover, increase in demand for effective CNS therapeutic options encourages major pharmaceutical companies to invest in R&D, thus creating future growth opportunities. Furthermore, rise in awareness regarding psychiatric disorders, surge in prevalence of mental illness & lifestyle-associated CNS disorders, and increase in geriatric population boost the growth of the global market. The rate of serious psychological distress among adolescents and young adults has been on a rise since past few years, which further fuels the demand for CNS therapeutics across the globe. However, stringent & protracted drug approval procedures and soaring prices of advanced treatments are projected to restrain the growth of the CNS therapeutics market. On the contrary, lucrative opportunities in emerging economies due to various factors such as rise in awareness regarding CNS disorders and increase in healthcare expenditure by government & non-government organizations are expected to provide immense opportunities for the manufacturers in the industry.
The World Health Organization and the American Association of Neurological Surgeons conduct various seminars to increase awareness about psychological disorders and their treatments. In addition, these organizations have helped to create groups in which patients can interact with each other as well as with the professionals and can have a holistic approach toward healing, which drives the market growth. Furthermore, advancements in technologies to develop superior drug delivery system and rise in R&D activities for introduction of novel drugs are anticipated to propel the market for CNS therapeutics. Moreover, upcoming pipeline therapeutics for CNS disorders by Healthcare giants such as Biogen, Inc. and Pfizer, Inc. is projected to accelerate the growth of the market. In addition, various other key players in the global CNS therapeutics market are heavily investing to bring superior therapeutics in the market, which provides remunerative opportunities for market expansion.
The global central nervous system therapeutics market is segmented into disease type, applications, and region. Based on disease type, the market is fragmented into infectious diseases, neurodegenerative diseases, autoimmune & inflammatory diseases, genetic disorders, cancers, trauma, and psychiatric disorders. The applications covered in the study include hospital, clinic, homecare, and others. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This report provides a comprehensive analysis and profiles of major players such as Pfizer, Inc., Biogen, Inc., Johnson & Johnson Services, Inc., Eli Lilly and Company, Inc., Merck & Co., Inc., AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Shire Plc, and Allergan Plc. The other players in the value chain include Cipla Limited, GlaxoSmithKline plc, Lupin Limited, Otsuka Pharmaceutical Co., Ltd., Lundbeck, and others.
KEY BENEFITS FOR STAKEHOLDERS
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
- Region-wise and country-wise market conditions are comprehensively analyzed in this report.
- The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the CNS therapeutics market are profiled in this report, and their strategies are analyzed thoroughly, which help to understand the competitive outlook of global market.
KEY MARKET SEGMENTS:
By Disease Type
- Infectious Diseases
- Neurodegenerative Diseases
- Autoimmune and Inflammatory Diseases
- Genetic Disorders
- Cancers
- Trauma
- Psychiatric Disorders
- Anxiety Disorders
- Substance Abuse Disorders
- Mood Disorders
- Others
By Application
- Hospital
- Clinic
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Central Nervous System (CNS) Therapeutics Market
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.